Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 12, 1996, Pages 1171-1176

  Thomson, A B R ^a   Mahachai, V ^a   Bailey, R J ^a   Kirdeikis, P ^a   Zuk, L ^a   Marriage, B ^a   Simpson, I ^a   Jamali, F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

duodenal ulcer; gastrin; nizatidine; pepsin; pH; ranitidine

Indexed keywords

GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; PEPSIN A; PLACEBO; PROSTAGLANDIN E2; RANITIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GASTRIN BLOOD LEVEL; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH PH;

EID: 0030464675     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb01847.x     Document Type: Article

References (25)

1. 2-receptor antagonists. N. Engl. J. Med. 1990; 323: 1672-80; 1749-55.
2. Mahachai V, Jamalim F, Thomson ABR. Effect of combination of antacid and cimetidine on 24 hour intragastric acidity in patients with asymptomatic duodenal ulcer. Clin. Ther. 1984; 6: 808-23.
3. Jones DB, Howden CW, Burget DW, Kerr GD, Hunt RH. Acid suppression in duodenal ulcer: A meta-analysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120-7.
4. Thomson ABR. Medical treatment of reflux disease: Options and priorities. Hepatogastroenterology 1992; 39 (Suppl. 1): 14-23.
5. ,-receptor antagonists. Aliment. Pharmacol. Ther. 1987; 1: 31-8.
6. Findlay JM, Prescott RJ, Sircus W. Comparative evaluation of water recovery test and fluoroscopic screening in positioning a nasogastric tube during gastric secretory studies. BMJ 1972; 4: 458-61.
7. Hunt RH. Non-responders to cimetidine, Part 1. In: Cimetidine in the 80's. Edinburgh: Churchill Livingstone 1981; 34-41.
8. 2 antagonists. Lancet 1989; i: 323.
9. Gray SP, Billings JA. Kinetic assay of human pepsin with albumin-bromphenol blue as subtrate. Clin. Chem 1983; 3:447-51.
10. Becton D. Gastrin Radioimnnmoassay Kit Method. 1986.
11. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-51.
12. Spaziani E, Silecchia G, Materia A et al. Nizatidine stimulates gastric intraluminal prostaglandins release in man. Gastroenterology 1991; 100: A166.
13. 2 concentrations and serum gastrin and nizatidine pharmacokinetics in healthy volunteers. J. Gastroenterol. Hepatol. 1996; (in press).
14. Farup PG. Compliance with anti-ulcer medication during short-term healing phase clinical trials. Aliment. Pharmacol. Ther. 1992; 6: 79-186.
15. 2 blockers: An emerging therapeutic problem. Scand. J. Gastroenterol. 1988; 23 (Suppl. 153): 81-8.
16. Delle-Fave G, Annibale B, Puoti M et al. Refractory peptic ulcer and Zollinger-Ellison syndrome: Problems of management. Ital. J. Gastroenterol. 1988; 20: 30-4.
17. Bardhan KD. Refractory duodenal ulcer. Gut 1984; 25: 711-17.
18. 2-antagonist nonresponders. Digestion 1992; 51: 186-92.
19. Brunner G, Creuzfeldt W, Harke V et al. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 1988; 39: 80-90.
20. 2-receptor antagonist non-responders. Lancet 1988; i: 128.
21. 2-receptor antagonists. Dig. Dis. Sci. 1990; 35: 976-83.
22. Hassan MA, Hobsley M. Positioning of subject and of nasogastric tube during a gastric secretion study. BMJ 1970; i: 458-60.
23. Collen MJ, Stanczakk V, Ciarleglio CA. Refractory duodenal ulcers (non-healing duodenal ulcers with standard doses of antisecretory medication). Dig. Dis. Sci. 1989; 34: 233-7.
24. Mahachai V, Walker K, Jamali F et al. Comparative effects of two cimetidine regimens on 24 hour intragastric acidity in patients with asymptomatic duodenal ulcer. Clin. Ther. 1984; 6: 259-81.
25. Alcala SR, Guardia J, Pajares J et al. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration. Aliment. Pharmacol. Ther. 1989; 3: 103-10.